Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Assay Development
 More »

  • Heightened Characterization of Therapeutic mAbs Using a Novel...
    antibody (mAb) therapeutics is required throughout therapeutic development and production. ... In this webinar, the speakers will introduce the Antibody Subunit/Domain Mapping assay, a ...
    5-15-2013
  • Improving Proteomics Approaches
    Even medium-throughput labs can be convinced that the assay accuracy, consistency, and ... on one's perspective), PureSpeed requires no programming or extensive method development. ...
    5-15-2013
  • Highlights from AACR
    The platform can be used to develop and validate cell lines for target identification and validation, and for assay development, disease modeling, and compound profiling. Active ...
    5-15-2013
  • Advertorial: Agilent Technologies
    ... Each workflow is designed to have maximum assay development flexibility controlled through simple inputs on a computer interface. Figure 2. The three main components of the ...
    5-15-2013
  • Diversifying Your Antibody Portfolio
    However, the complexity and/or lack of immunogenicity of certain antigens can prevent the successful development of suitable, assay-specific, diagnostic, or therapeutic antibodies. ...
    5-15-2013
  • Advertorial: Determining the Antioxidant Capacity of Beverages
    ... function greatly facilitate the assay handling, making the Infinite F200 PRO ... Application Scientist Research and Development Katrin.Flatscher@tecan.com ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    ... and commercialize diagnostics that will apply Primera Dx's ICEPlex System assay-development platform in early-phase biomarker and drug development studies and clinical ...
    5-9-2013
  • Cancer Diagnostics, Pushing the Boundaries
    ... in a format that can be run on any NGS platform, we can increase throughput, reduce cost, and make the assay ready for in vitro diagnostic kit development," explained Shuber. ...
    5-8-2013
  • Harnessing the Power of Kinase Inhibitors
    The assay development and high-throughput screening system at the European ScreeningPort, Hamburg, Germany. The ~600 kinases that make up the human kinome comprise a group of ...
    5-8-2013
  • Foundation Medicine Taps Sloan-Kettering Clinical, Genomics Expertise...
    Medicine to develop a best-in-class assay for hematologic cancers because we view ... Foundation Medicine said this product in development complements its FoundationOne(tm) ...
    5-2-2013
  • New International Collaboration Aims to Develop Drugs, Diagnostics...
    drug discovery, medicinal chemistry, biochemical and cellular assay development, ADME/tox, DMPK, and multiple in vivo efficacy/toxicology models, among other things. ...
    5-2-2013
  • Biomarkers Take Center Stage
    ... Andrew Gribben is a clinical assay and development scientist at Randox Laboratories, based in Northern Ireland, U.K. The company utilizes academic and industrial collaborators ...
    5-1-2013
  • Human iPSC-Derived Hepatocytes
    ... limitations from development while focusing on safer and more in vivo-stable therapeutics. ... by ATP production with the CellTiter-Glo® Assay (Promega) in the presence of compound. ...
    5-1-2013
  • DNA Reference Standard
    the development of personalized medicines. The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using ...
    5-1-2013
  • Kidney Toxicity Panels
    that advance scientific research and development efforts and support the introduction of ... research. The assays are offered as kits that include everything needed to run the assay.
    5-1-2013
  • More »

    Journal Articles

  • Assays on the Influence of Biomaterials on Allogeneic Rejection...
    Kim S. Jones
    Tissue Engineering, Part B: Reviews
    This review describes methods of measuring responses of macrophages, dendritic cells, and T cells stimulated in vitro and in vivo and addresses key factors in assay development. ...
  • Influence of Platelet-Derived Growth Factor-AB on Tissue Development...
    Simone Wirz, Maren Dietrich, Thomas C. Flanagan, Gudrun Bokermann, Wolfgang Wagner, Thomas Schmitz-Rode, Stefan Jockenhoevel
    Tissue Engineering, Part A
    factor (PDGF)-AB, which may have a consequent positive effect on tissue development. ... of human umbilical cord artery smooth muscle cells (HUASMCs) was studied using XTT assay. ...
  • Correlation Between Compositional and Mechanical Properties of...
    Chun-hei Li, Tsz-Kit Chik, Alfonso H.W. Ngan, Stanley C.H. Chan, Daisy K.Y. Shum, Barbara P. Chan
    Tissue Engineering, Part A
    using histological and biochemical methods and a microplate compression assay. ... and therefore contributes to future development of novel cartilage repair strategies.
  • Preadipocytes Stimulate Ductal Morphogenesis and Functional Differenti...
    Xiuli Wang, Xiaohui Zhang, Lin Sun, Balajikarthick Subramanian, Maricel V. Maffini, Ana Soto, Carlos Sonnenschein, David L. Kaplan
    Tissue Engineering, Part A
    secreted by the predifferentiated hASCs, based on results from a cytokine blocking assay. ... organization and epithelial morphogenesis in normal or diseased breast development.

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll